Activist investor Elliott builds stake in life-science tools supplier Bio-Rad Laboratories, WSJ reports
May 17 (Reuters) - Activist investor Elliott Investment Management has built a sizable stake in Bio-Rad Laboratories BIO.N and plans to push the supplier of life-science tools and diagnostics products to boost its underperforming stock price, the Wall Street Journal reported on Sunday. Reuters could not immediately verify the WSJ report. (Reporting by Rishabh Jaiswal in Bengaluru; Editing by Subhranshu Sahu) ((rishabh.jaiswal@thomsonreuters.com; +91 9916719147))
Recent news on Bio-Rad Laboratories
See all newsUS RESEARCH ROUNDUP-Cencora, Dave, Uber
Bio-Rad Laboratories, Inc. reports results for the quarter ended September 30 - Earnings Summary
Bio-Rad's Q3 revenue comes slightly above estimates on Clinical Diagnostics growth
Brief: Bio-Rad Q3 EBIT Margin -7.6%
Bio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary